Washington (NEXSTAR) —U.S. Regulatory Authorities approved the extension of the COVID-19 booster to Americans vaccinated with Moderna or Johnson & Johnson on Wednesday, the first to be received by anyone eligible for additional doses. He said he could get a different brand.
The Food and Drug Administration’s decision marks a major step towards expanding the US booster campaign, which began with an additional dose of Pfizer vaccine last month. The Centers for Disease Control and Prevention will also consult a panel of experts later this week before finalizing its own official recommendations on who should get boosters and when.
“Available data suggest weakened immunity in some fully vaccinated populations. The availability of these licensed boosters continues for COVID-19 disease. It’s important for your protection. “
She said the country was “actively fighting the pandemic”, adding that the vaccine would continue to be the safest and most effective way to prevent COVID-19 and subsequent hospitalizations and deaths. Praised the decision.
The latest move has expanded the number of Americans targeted for boosters by tens of millions and officially allows “mixing and matching” of shots. This had side effects, especially one brand, but still proven protection of vaccination.
“Emergency authorization amendments to include a single booster dose in an eligible population are based on available data and information and are members of an advisory board supporting the use of booster doses of these vaccines. Follow the input from, “Eligible population,” said Peter Marks, MD, Ph.D., Director of the FDA’s Center for Biologics Evaluation and Research. Says.
Specifically, the FDA has issued a third Moderna six months after the last shot to elderly people and other people at high risk of COVID-19 due to health problems, work, or living conditions. Approved the shot. One big change: Moderna’s booster will be half the dose used for the first two shots, based on company data showing that it was enough to boost immunity again.
For J & J’s one-shot vaccine, the FDA stated that all US recipients should receive a second dose at least two months after the first vaccination.
FDA decisions differ due to different vaccine manufacturing methods and dosing schedules. In addition, the J & J vaccine has consistently shown lower levels of efficacy than the two-shot Moderna and Pfizer vaccines.
The Associated Press contributed to this report.
Suggest a fix
FDA approves Moderna and J & J booster shots, OK mix and match | WGN Radio 720
Source link FDA approves Moderna and J & J booster shots, OK mix and match | WGN Radio 720